Investing.com - Lifecore Biomedical (NASDAQ: LFCR) reported second quarter EPS of $-0.25, $0.02 better than the analyst estimate of $-0.27. Revenue for the quarter came in at $32.56M versus the consensus estimate of $30.18M.
Lifecore Biomedical's stock price closed at $6.66. It is up 23.79% in the last 3 months and up 5.38% in the last 12 months.
Lifecore Biomedical saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Lifecore Biomedical's stock price’s past reactions to earnings here.
According to InvestingPro, Lifecore Biomedical's Financial Health score is "good performance".
Check out Lifecore Biomedical's recent earnings performance, and Lifecore Biomedical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar